Expression of tumor stem cell markers CD133-2, CD24 and CD44S in head and neck squamous cell carcinoma tissues and their clinical significances
10.3760/cma.j.issn.1006-9801.2013.03.002
- VernacularTitle:肿瘤干细胞标志物CD133-2、CD24和CD44S在头颈部鳞状细胞癌组织中的表达及其临床意义
- Author:
Lei CAO
;
Chao LI
;
Hong ZHANG
;
Yinghong YANG
;
Qiang CHEN
;
Yunbin YE
- Publication Type:Journal Article
- Keywords:
Head and neck neoplasms;
Carcinoma,squamous cell;
Neoplastic stem cells;
CD133-2;
CD24;
CD44s
- From:
Cancer Research and Clinic
2013;(3):148-151,155
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the expressions and significances of the tumor stem cell markers CD133-2,CD24 and CD44s in head and neck squamous cell carcinoma (HNSCC) tissues and their association with the clinical pathologic characteristics.Methods Expressions of CD133-2,CD24 and CD44s were analyzed by immunohistochemistry (SP) in 83 cases of primary HNSCC tissues and 46 cases of normal epithelia.Clinicopathological indexes were assessed.Results In primary HNSCC tissues and normal epithelia,the expression rates of CD133-2 and CD24 were 9.64 ％ (8/83),21.74 ％ (10/46) and 90.36 ％ (75/83),46.67 ％ (21/46)respectively,which had statistically significances (x2 =15.040,5.818,P ＜ 0.05).CD44s expression was detected in primary HNSCC tissues and normal epithelia,but their staining scores had statistical significance (Z =-4.262,P ＜ 0.05).In primary HNSCC tissues,the expression of CD133-2 had negative correlation with differentiation degree (x2 =7.246,P ＜ 0.05),but CD24 and CD44s had positive correlation with differentiation degree (x2 =9.005,44.765,P ＜ 0.05).In addition,the expression of CD44s in primary HNSCC tissues had negative correlation with T classification (x2 =4.650,P ＜ 0.05).Conclusion The expressions of CD24 and CD44s in primary HNSCC tissues are highly up-regulated with tumor cells differentiation,and further research needs to be performed to discover whether or not CD24 and CD44s could be the markers of tumor stem cells of HNSCC.The expression of CD133-2 in primary HNSCC tissues is highly down-regulated with tumor cell differentiation.As one of the tumor stem cell markers of HNSCC,CD133-2 may play an important role in the development and clinical outcomes of tumor.
